Recently, mutations of genes crucial for hematopoiesis (RUNX1, ASXL1, WT1, NRAS, KRAS, TET2, CBL, TP53, IDH and IKZF) were reported to occur in 76.9% of CML-BC patients. The gene discussed is RUNX1; the disease is breast cancer.